TickerFactsScreenerDevelopers

Cytosorbents Corp (CTSO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $1.60M2010: $1.06M2011: $1.19M2012: $1.73M2013: $2.18M2014: $3.61M2015: $5.32M2016: $5.25M2017: $17.32M2018: $22.37M2019: $12.23M2020: $71.42M2021: $52.14M2022: $22.14M2023: $14.13M2024: $3.28M2025: $6.25M$6.25M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$6.25M+90.5%
2024$3.28M-76.8%
2023$14.13M-36.2%
2022$22.14M-57.5%
2021$52.14M-27.0%
2020$71.42M+483.9%
2019$12.23M-45.3%
2018$22.37M+29.1%
2017$17.32M+230.2%
2016$5.25M-1.3%
2015$5.32M+47.5%
2014$3.61M+65.2%
2013$2.18M+26.2%
2012$1.73M+45.7%
2011$1.19M+12.4%
2010$1.06M-33.8%
2009$1.60M—